Complementary targeted experiments including the modulation of TRPV activation and in particular TRPV2 could confirm the mechanism involved and provide a potential strategy to modulate obesity and related disorders. This evidence concerns the gene TRPV2 and obesity due to melanocortin 4 receptor deficiency.